Drug intelligence / Profile preview

Glucose Rapid Spray

Development stage: Unknown
Lead developer: Generex Biotechnology
Modality: Small Molecules
Administration: Oral

Overview

Glucose Rapid Spray is an over-the-counter oral glucose supplement designed for individuals with diabetes to manage and prevent mild to moderate hypoglycemia. The product utilizes a buccal delivery system, where the glucose is sprayed onto the inner cheeks and absorbed through the mucosal lining, allowing for rapid entry into the bloodstream. It is marketed as a portable and convenient alternative to glucose tablets or gels, intended to stabilize falling blood sugar levels before they reach a critical state. It is available in various flavors and is typically used in doses of 5-10 sprays. It is not intended for the emergency treatment of severe hypoglycemia.

Brand names: Glucose Rapid Spray
Other names: Oral glucose spray

Beyond the preview

Go deeper on Glucose Rapid Spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose Rapid Spray.

Explore the full profile